株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

バイオチップの世界市場の将来予測

Global Biochips Market Forecast 2019-2027

発行 Inkwood Research 商品コード 603658
出版日 ページ情報 英文 127 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.65円で換算しております。
Back to Top
バイオチップの世界市場の将来予測 Global Biochips Market Forecast 2019-2027
出版日: 2019年03月09日 ページ情報: 英文 127 Pages
概要

当レポートでは、世界のバイオチップ市場の将来展望について分析し、製品の特性や市場の構造、主な市場促進・抑制要因、全体的な市場規模の動向見通し (今後9年間分)、種類別・基板材料別・エンドユーザー別および地域別の詳細動向、関連産業との連関構造と市場機会、市場競争環境、主要企業のプロファイルなどを調査しております

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 母体市場分析:ゲノミクス/プロテオミクス市場
  • 「バイオチップ」市場の語源
  • 市場の定義と範囲
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題

第5章 種類別の市場

  • DNAチップ
    • 農業・バイオテクノロジー
    • がん診断・治療
    • 創薬
    • 遺伝子発現
    • ゲノミクス
    • SNP (一塩多基型) ジェノタイピング
    • その他
  • ラブオンチップ (Lab-on-a-Chip)
    • 臨床診断
    • 創薬
    • ゲノミクス
    • POC (Point of Care) 診断/IVS (体外診断)
    • プロテオミクス
    • その他
  • タンパク質チップ
    • 診断
    • 創薬
    • 発現プロファイリング
    • ハイ・スループットスクリーニング
    • プロテオミクス
    • その他
  • その他のチップ
    • 細胞アレイ
    • 組織アレイ

第6章 基板材料別の市場

  • ガラス
  • ポリマー
  • シリコン
  • その他の基板材料

第7章 エンドユーザー別の市場

  • バイオテクノロジー企業/製薬企業
  • 病院/診断センター
  • 教育・研究機関

第8章 主な分析指標

  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • ベンダー環境
  • バリューチェーン分析
    • 研究開発 (R&D)
    • 原材料
    • 製造
    • 卸売業者/小売業者/流通業者
    • エンドユーザー
  • 法令・政策・規制の枠組み
  • 主な購入基準
    • コスト
    • 用途
    • 製品の種類
  • 投資分析
    • 地域別の投資機会
    • エンドユーザー分類別の投資機会
    • バイオチップの種類別の投資機会

第9章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランス、イタリア、スペインなど)
  • アジア太平洋地域 (中国、日本、インド、韓国、オーストラリアなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 競争環境

  • 市場シェア分析
  • 主要企業の分析 (全4社)
  • 企業戦略
    • 事業提携・協力
    • 企業合併・買収 (M&A)
  • 企業プロファイル
図表

LIST OF TABLES

  • TABLE 1: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN UNITED STATES IN 2017
  • TABLE 3: NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
  • TABLE 4: ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
  • TABLE 5: ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
  • TABLE 6: GLOBAL BIOCHIPS MARKET, BY TYPE, 2019-2027, (IN $ MILLION)
  • TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 8: GLOBAL DNA CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 9: GLOBAL LAB ON A CHIP MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 10: GLOBAL LAB ON A CHIP MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 11: GLOBAL PROTEIN CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 12: GLOBAL PROTEIN CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 13: GLOBAL OTHER CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 14: GLOBAL OTHER CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 15: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 16: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • TABLE 17: GLOBAL GLASS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 18: GLOBAL POLYMERS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 19: GLOBAL SILICON MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 20: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 21: GLOBAL BIOCHIPS MARKET, BY END-USERS, 2019-2027 (IN $ MILLIONS)
  • TABLE 22: GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 23: GLOBAL HOSPITALS & DIAGNOSTICS CENTERS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 24: GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 25: OPPORTUNITY MATRIX
  • TABLE 26: VENDOR LANDSCAPE
  • TABLE 27: LEGAL, POLICY & REGULATORY FRAMEWORK
  • TABLE 28: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 29: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 30: EUROPE BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 31: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 32: REST OF WORLD BIOCHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 33: LIST OF PARTNERSHIP & COLLABORATION
  • TABLE 34: LIST OF MERGERS & ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOCHIPS MARKET, BY END-USER, 2018 & 2027 (IN %)
  • FIGURE 2: NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 3: ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 4: EVOLUTION & TRANSITION OF BIOCHIPS
  • FIGURE 5: WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
  • FIGURE 6: UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)
  • FIGURE 7: COMPARISON OF HEALTHCARE SPENDING PER CAPITA & OUT OF THE POCKET HEALTH EXPENDITURE
  • FIGURE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 9: GLOBAL DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
  • FIGURE 10: GLOBAL DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
  • FIGURE 11: GLOBAL DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 12: GLOBAL DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
  • FIGURE 13: GLOBAL DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 14: GLOBAL DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)
  • FIGURE 15: GLOBAL DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 16: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 17: GLOBAL LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 18: GLOBAL LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 19: GLOBAL LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 20: GLOBAL LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS), 2019-2027 (IN $ MILLION)
  • FIGURE 21: GLOBAL LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 22: GLOBAL LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 23: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 24: GLOBAL PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 25: GLOBAL PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 26: GLOBAL PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
  • FIGURE 27: GLOBAL PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
  • FIGURE 28: GLOBAL PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 29: GLOBAL PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 30: GLOBAL BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 31: GLOBAL OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 32: GLOBAL OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 33: GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 34: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 35: GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
  • FIGURE 36: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 37: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
  • FIGURE 38: GLOBAL BIOCHIPS MARKET, BY HOSPITALS & DIAGNOSTICS CENTRES, 2019-2027 (IN $ MILLIONS)
  • FIGURE 39: GLOBAL BIOCHIPS MARKET, BY ACADEMIC & RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
  • FIGURE 40: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 41: VALUE CHAIN ANALYSIS
  • FIGURE 42: KEY IMPACT ANALYSIS
  • FIGURE 43: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY REGION
  • FIGURE 44: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY END-USER
  • FIGURE 45: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY TYPE
  • FIGURE 46: GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 47: UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 48: CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 49: UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 50: FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 51: GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 52: ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 53: SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 54: REST OF EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 55: CHINA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 56: JAPAN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 57: INDIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 59: AUSTRALIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 60: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 61: LATIN AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 62: MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • FIGURE 63: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2018 (IN %)
目次
Product Code: 12926

KEY FINDINGS

The global biochips market is expected to grow considerably over the forecast years of 2019-2027. Factors like growing investments for R&D, government funding and increasing demand for personalized medicines is expected to lead to a 20.63% CAGR for this market by the end of 2027. Extensive diagnostic application and the major integration of biochips for analytical studies of effectors triggering changes in the environment are influential for the uptake of biochips in the current market.

MARKET INSIGHTS

The global biochip market is very dynamic with respect to the presence of many international players. Most of these companies are engaged for the determination of new varieties of biochip research and development. They are trying to compete with each other by providing the same characteristics at similar prices or by similar features at competitive prices. The progress in the technology and innovations of the biochips, biotechnology, and biosensors have resulted in several new applications of biomedical devices, thereby, providing several opportunities for the biochips market to expand.

Segmentation of the global biochip market is done according to the substrates, types, and end users.

REGIONAL INSIGHTS

The geographical segmentation of the global biochips market is carried out over North America, Asia-Pacific, Europe and the Rest of World. The Asia Pacific biochips market is expected to rise with the highest CAGR over the forecast period of 2019-2027, driven by the emerging economies of countries like Japan, India, and China. The increasing investment in the biochips R&D, supportive incentives from the governments and the solidifying presence of CROs in the region are propagating the market expansion.

Conversely, North America leads the market by capturing the largest market share of xx% in the year 2018. Large-scale research projects in biosciences coupled with the advancements in the pharmaceutical & biotechnology sector of North America are presenting lucrative opportunities to the regional market for further developments.

COMPETITIVE INSIGHTS

Collaboration, partnerships, acquisition, & product launch are some of the key strategies followed by several enterprises within the global biochips market. Eminent companies like the IMGENEX, Thermo Fisher Scientific Inc., Illumina Inc., Samsung Electronics Inc., Cepheid Inc., Fluidigm Corporation, Biochain Institute Inc., Agilent Technology Inc., Gamida for Life Group, Bio-Rad Laboratories Inc., Merck GmbH, OriGene Technologies Inc., Cybrdi Inc., PerkinElmer Inc. and bioMerieux SA are competitively operating in the global biochips market.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY & FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NORTH AMERICA DOMINATES THE OVERALL MARKET
    • 3.2.2. ASIA PACIFIC IS THE FASTEST EVOLVING REGIONAL MARKET
    • 3.2.3. DNA CHIPS ACCOUNTS FOR THE LARGEST REVENUE SHARE OF TYPE SEGMENT
    • 3.2.4. HOSPITALS & DIAGNOSTICS CENTRES - KEY END-USER VERTICAL
    • 3.2.5. PROTEIN CHIP TYPE IS PROJECTED TO RISE AT HIGHEST GROWTH RATE

4. MARKET DYNAMICS

  • 4.1. PARENT MARKET ANALYSIS: GENOMICS & PROTEOMICS MARKET
  • 4.2. ETYMOLOGY OF BIOCHIPS MARKET
  • 4.3. MARKET DEFINITION & SCOPE
  • 4.4. MARKET DRIVERS
    • 4.4.1. RISING INCIDENCES OF CANCER
    • 4.4.2. INCREASED GOVERNMENT FUNDING, R&D INVESTMENT IN BIOTECHNOLOGY
    • 4.4.3. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 4.4.4. SIGNIFICANT GROWTH IN THE HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
  • 4.5. MARKET RESTRAINTS
    • 4.5.1. LACK OF HEALTHCARE COVERAGE
    • 4.5.2. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 4.5.3. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
  • 4.6. MARKET OPPORTUNITIES
    • 4.6.1. TECHNOLOGICAL ADVANCEMENT IN THE BIOTECHNOLOGY
    • 4.6.2. IMMENSE GROWTH OPPORTUNITIES IN SUB-CONTINENT OF ASIA
    • 4.6.3. GROWING APPLICATIONS OF BIOCHIPS
  • 4.7. MARKET CHALLENGES
    • 4.7.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 4.7.2. LACK OF COMMON REGULATORY STANDARDS
    • 4.7.3. HIGH INSTRUMENTATION COST

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSTICS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS APPLICATIONS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS)
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP APPLICATIONS
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIP APPLICATIONS
  • 5.4. OTHER CHIPS
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USERS

  • 7.1. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS & DIAGNOSTICS CENTRES
  • 7.3. ACADEMIC & RESEARCH INSTITUTE

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCE MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF SUPPLIERS
    • 8.1.4. BARGAINING POWER OF BUYERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. OPPORTUNITY MATRIX
  • 8.3. VENDOR LANDSCAPE
  • 8.4. VALUE CHAIN ANALYSIS
    • 8.4.1. RESEARCH & DEVELOPMENT
    • 8.4.2. RAW MATERIALS
    • 8.4.3. MANUFACTURING
    • 8.4.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 8.4.5. END-USERS
  • 8.5. LEGAL, POLICY & REGULATORY FRAMEWORK
  • 8.6. KEY BUYING CRITERIA
    • 8.6.1. COST
    • 8.6.2. APPLICATIONS
    • 8.6.3. PRODUCT TYPE
  • 8.7. INVESTMENT ANALYSIS
    • 8.7.1. BY REGION
    • 8.7.2. BY END-USERS
    • 8.7.3. BY BIOCHIPS TYPE

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. UNITED KINGDOM
    • 9.2.2. FRANCE
    • 9.2.3. GERMANY
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. INDIA
    • 9.3.4. SOUTH KOREA
    • 9.3.5. AUSTRALIA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. KEY COMPANY ANALYSIS
  • 10.3. CORPORATE STRATEGIES
    • 10.3.1. PARTNERSHIP & COLLABORATION
    • 10.3.2. MERGERS & ACQUISITIONS
  • 10.4. COMPANY PROFILES
    • 10.4.1. AGILENT TECHNOLOGY INC.
    • 10.4.2. BIOCHAIN INSTITUTE INC.
    • 10.4.3. BIOMERIEUX SA
    • 10.4.4. BIO-RAD LABORATORIES INC.
    • 10.4.5. CEPHEID INC.
    • 10.4.6. CYBRDI INC.
    • 10.4.7. FLUIDIGM CORPORATION
    • 10.4.8. GAMIDA FOR LIFE GROUP
    • 10.4.9. ILLUMINA INC.
    • 10.4.10. IMGENEX
    • 10.4.11. MERCK GMBH
    • 10.4.12. ORIGENE TECHNOLOGIES INC.
    • 10.4.13. PERKINELMER INC.
    • 10.4.14. SAMSUNG ELECTRONICS INC.
    • 10.4.15. THERMO FISHER SCIENTIFIC INC.
Back to Top